The cardiovascular effects of a new, long-acting, sympathomimetic amine, Aramine, are described. Cardiac output, aortic pressure, coronary flow, and ventricular stroke work rise while atrial pressures fall. A sustained increase in myocardial contractility is produced and the myocardium does not require more coronary flow per unit of ventricular work after its administration. The circulatory effects of ventricular failure produced by restricting coronary flow are reversed by the drug. The objectives of this communication will be to demonstrate: (1) the effect of Aramine on atrial and arterial pressures, cardiac output, coronary flow and peripheral vascular resistance; (2) the effect of the drug on ventricular function (myocardial contractility) as well as its effect on the systemic vascular bed; (3) the effect of Aramine on coronary flow requirements per unit of ventricular work; (4) the drug's effect on the hypotension and low cardiac output induced by coronary insufficiency. An attempt will also be made to indicate why a "vasopressor" agent is more likely to be therapeutically effective in cardiogenic shock if it also increases myocardial contractility.
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survival rate of dogs subjected to oligemic hypotension. 4 The objectives of this communication will be to demonstrate: (1) the effect of Aramine on atrial and arterial pressures, cardiac output, coronary flow and peripheral vascular resistance; (2) the effect of the drug on ventricular function (myocardial contractility) as well as its effect on the systemic vascular bed; (3) the effect of Aramine on coronary flow requirements per unit of ventricular work; (4) the drug's effect on the hypotension and low cardiac output induced by coronary insufficiency. An attempt will also be made to indicate why a "vasopressor" agent is more likely to be therapeutically effective in cardiogenic shock if it also increases myocardial contractility.
For the purpose of clarity it is best to define the term myocardial contractility as used herein. It is quantitatively described by the relationship between ventricular filling pressure and the stroke work of that ventricle throughout the range of its function.5 METHOD 1. General. The methods used were similar to those described in previous publications.5 ' 6 The experiments were done in anesthetized (morphine-chloralose-urethane) open-chest dogs with a complete circulation. Briefly, they involved the continuous electrical recording of (a) pressures in the left and right atria and the pulmonary artery and aorta.7 (b) the total systemic blood flow with the Potter Electro- figure 3 . Changes similar to those shown in figure 3 were obtained in the same dog 19 minutes earlier as the result of giving one microgram per kilogram of norepinephrine (Levophed) intravenously. The only significant difference was the transient character of the norepinephrine response. The dog studied in figure 3 was anemic, the hematocrit being 23.7 per cent, thus accounting for the high coronary blood flows recorded.12
The hemodynamic result of a large dose of (fig. 4A) , ill the heart with all anemic or a nonspecific type of failure ( fig. 6A ) and in the heart in which failure is due to coronary insufficiency ( fig. 7) . With a single intravenous dose of 0.05 mg. per kilogram the increase in myocardial contractility lasts for more than one hour ( fig. 6A ).
When graded doses were given it was seen that with small doses the effect was primarily on the myocardium and that further doses caused an increase ill peripheral vascular resistance and tone. A differentiation of the effect of this drug on the myocardium and systemic vessels was also demonstrated by the time dissociation technic, using single intravenous doses, of 0.03 to 0.1 mg. per kilogram.
There can be little doubt that both effects occur and are of significance. It is of additional interest that the myocardium did not require a greater blood flow per unit of work performed after the administration of this agent ( fig. 6B ), nor did it produce significant arrhythmias in the presence of severe myocardial hypoxia ( fig. 7) .
It was realized how approximate must be the attempt to simulate clinical coronary insufficiency experimentally. Nevertheless, in the experiment shown in figure 7 , acute coronary insufficiency was induced as shown by the fall of arterial pressure, cardiac output and stroke work with a rising left atrial pressure when coronary flow was arbitrarily restricted.6 It is of considerable interest that, with the coronary screw clamp still in place, the administration of Aramine was followed by an elevation of cardiac output, aortic pressure and coronary flow to or near control levels; and, as important, the left atrial pressure fell below control levels after the drug arrived at the myocardium.
Somehow the view has become widespread that a "vasopressor" agent which elevates arterial pressure solely by its effect on peripheral vascular resistance has a peculiar virtue. "The aim of the use of vasopressor drugs in the treatment of shock following acute myocardial infarction is to increase the mean aortic pressure and thus reestablish an adequate coronary blood flow. figure  5 and the tracing in figure 7 2. Los efectos de la droga en la producci6n total cardiaca, circulaci6n coronaria, presiones atriales y arteriales y resistencia periferal vascular han sido presentados.
3. En pequefias dosis "Aramine" produce mejoria sorprendente en las curvas de funci6n ventricular de ambos, ventrlculo derecho e izquierdo (mayor trabajo por contraccidn a cualquier presi6n de henchimiento). Dosis subsiguientes no mejoran mis la contracci6n del miocardio pero aumentan la resistencia perifero-vascular y el tono.
4. Este efecto bivalente en el coraz6n y periferia tambi6n se demostr6 por la t&cnica de disociaci6n de tiempo. 5 . El miocardio no requiere una circulaci6n coronaria mayor por unidad de trabajo luego de la administraci6n de "Aramine".
6. Insuficiencia coroniaria aguda fu6 inducida ajustando una grampa al tubo de alimentaci6n de la arteria coronaria principal izquierda. Esto produjo un decremento en presi6n arterial, producci6n cardiaca y trabajo por contracci6n ventricular y un incremento en presi6n atrial izquierda. La subsiguiente inyecci6n intravenosa de "Aramine" (con la grampa tornillo ain en sitio) reintegr6 los valores a, o cerca de los niveles conztroles.
7. Los autores seriamente dudan la premisa de que uin ageute para el tratamiento del choque cardiogenico pueda producir su efecto solamente o predominantemente por la vasoconstriccion periferica.
